It's that time again! The Lightning Round bell has rung, and Jim Cramer gave his take on a few favorite audience stocks:

J.C. Penney: "We do not recommend J.C. Penney. We do not think it is going to be a great stock, we feel it is going to just muddle through. That's not what I want out of a retailer. I think Wal-Mart is going to do better."

Mobileye: "I do think that Mobileye could have a good quarter. But this is a stock that really had a remarkable ride, and there seems to be profit taking everywhere. I think the quarter is going to be fine."

Diana Shipping: "Too dangerous for me."

Merrimack Pharmaceuticals: "We have recommended Merrimack as a spec. As long as you understand that this is a spec, we like this kind of company."

Biogen: "Everyone has turned on Biogen, and everyone has decided that there is nothing. I think this is a mistake. I actually want to be a buyer."

----------------------------------------------------------
Read more from Mad Money with Jim Cramer
Cramer Remix: This coming event disturbs me
Cramer warns: Don't be crude, short sellers, be shrewd
Cramer's Gameplan: This could send Alibaba higher
----------------------------------------------------------

Alnylam Pharmaceuticals: "We like this thing. This has got a whole other way in personalized medicine, and we think it's a terrific stock."

General Electric: "I think GE is a buy... It just doesn't have the momentum I like, but I think the stock holds up very well despite all of the money they spent in the oil patch, and therefore I think things are getting better there."

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com